{"id":"https://openalex.org/W2941344810","doi":"https://doi.org/10.1186/s12918-019-0706-y","title":"How to schedule VEGF and PD-1 inhibitors in combination cancer therapy?","display_name":"How to schedule VEGF and PD-1 inhibitors in combination cancer therapy?","publication_year":2019,"publication_date":"2019-03-13","ids":{"openalex":"https://openalex.org/W2941344810","doi":"https://doi.org/10.1186/s12918-019-0706-y","mag":"2941344810","pmid":"https://pubmed.ncbi.nlm.nih.gov/30894166"},"language":"en","primary_location":{"id":"doi:10.1186/s12918-019-0706-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12918-019-0706-y","pdf_url":"https://bmcsystbiol.biomedcentral.com/track/pdf/10.1186/s12918-019-0706-y","source":{"id":"https://openalex.org/S92363890","display_name":"BMC Systems Biology","issn_l":"1752-0509","issn":["1752-0509"],"is_oa":true,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Systems Biology","raw_type":"journal-article"},"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://bmcsystbiol.biomedcentral.com/track/pdf/10.1186/s12918-019-0706-y","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033033981","display_name":"Xiulan Lai","orcid":"https://orcid.org/0000-0002-2764-8937"},"institutions":[{"id":"https://openalex.org/I78988378","display_name":"Renmin University of China","ror":"https://ror.org/041pakw92","country_code":"CN","type":"education","lineage":["https://openalex.org/I78988378"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiulan Lai","raw_affiliation_strings":["Institute for Mathematical Sciences, Renmin University of China, Beijing, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Mathematical Sciences, Renmin University of China, Beijing, People's Republic of China","institution_ids":["https://openalex.org/I78988378"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027260022","display_name":"Avner Friedman","orcid":"https://orcid.org/0000-0002-7875-174X"},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Avner Friedman","raw_affiliation_strings":["Mathematical Bioscience Institute & Department of Mathematics, Ohio State University, Columbus, OH, USA. afriedman@math.osu.edu","Mathematical Bioscience Institute & Department of Mathematics, Ohio State University, Columbus, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mathematical Bioscience Institute & Department of Mathematics, Ohio State University, Columbus, OH, USA. afriedman@math.osu.edu","institution_ids":[]},{"raw_affiliation_string":"Mathematical Bioscience Institute & Department of Mathematics, Ohio State University, Columbus, OH, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5027260022"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7024,"has_fulltext":true,"cited_by_count":34,"citation_normalized_percentile":{"value":0.83451246,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"13","issue":"1","first_page":"30","last_page":"30"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.861299991607666,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11829","display_name":"Mathematical Biology Tumor Growth","score":0.861299991607666,"subfield":{"id":"https://openalex.org/subfields/2611","display_name":"Modeling and Simulation"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.06599999964237213,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.01600000075995922,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"Cancer therapy","score":0.5979559421539307},{"id":"https://openalex.org/keywords/vegf-receptors","display_name":"VEGF receptors","score":0.5782955884933472},{"id":"https://openalex.org/keywords/systems-biology","display_name":"Systems biology","score":0.5242528915405273},{"id":"https://openalex.org/keywords/cancer","display_name":"Cancer","score":0.49271467328071594},{"id":"https://openalex.org/keywords/schedule","display_name":"Schedule","score":0.4629204571247101},{"id":"https://openalex.org/keywords/computational-biology","display_name":"Computational biology","score":0.45840078592300415},{"id":"https://openalex.org/keywords/antiangiogenic-therapy","display_name":"Antiangiogenic therapy","score":0.4247048497200012},{"id":"https://openalex.org/keywords/cancer-research","display_name":"Cancer research","score":0.3851589858531952},{"id":"https://openalex.org/keywords/medicine","display_name":"Medicine","score":0.37588879466056824},{"id":"https://openalex.org/keywords/bioinformatics","display_name":"Bioinformatics","score":0.34817835688591003},{"id":"https://openalex.org/keywords/computer-science","display_name":"Computer science","score":0.329833447933197},{"id":"https://openalex.org/keywords/biology","display_name":"Biology","score":0.32897478342056274},{"id":"https://openalex.org/keywords/internal-medicine","display_name":"Internal medicine","score":0.2530495524406433}],"concepts":[{"id":"https://openalex.org/C2983331546","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer therapy","level":3,"score":0.5979559421539307},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.5782955884933472},{"id":"https://openalex.org/C152662350","wikidata":"https://www.wikidata.org/wiki/Q815297","display_name":"Systems biology","level":2,"score":0.5242528915405273},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49271467328071594},{"id":"https://openalex.org/C68387754","wikidata":"https://www.wikidata.org/wiki/Q7271585","display_name":"Schedule","level":2,"score":0.4629204571247101},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.45840078592300415},{"id":"https://openalex.org/C2992356464","wikidata":"https://www.wikidata.org/wiki/Q574834","display_name":"Antiangiogenic therapy","level":3,"score":0.4247048497200012},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3851589858531952},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37588879466056824},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.34817835688591003},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.329833447933197},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32897478342056274},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2530495524406433},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/s12918-019-0706-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12918-019-0706-y","pdf_url":"https://bmcsystbiol.biomedcentral.com/track/pdf/10.1186/s12918-019-0706-y","source":{"id":"https://openalex.org/S92363890","display_name":"BMC Systems Biology","issn_l":"1752-0509","issn":["1752-0509"],"is_oa":true,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Systems Biology","raw_type":"journal-article"},{"id":"pmid:30894166","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30894166","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC systems biology","raw_type":null},{"id":"pmh:oai:doaj.org/article:4e8aa9199e2f47b4be49ea56dfc3cdfe","is_oa":false,"landing_page_url":"https://doaj.org/article/4e8aa9199e2f47b4be49ea56dfc3cdfe","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BMC Systems Biology, Vol 13, Iss 1, Pp 1-18 (2019)","raw_type":"article"},{"id":"pmh:oai:europepmc.org:5425562","is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6427900","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1186/s12918-019-0706-y","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12918-019-0706-y","pdf_url":"https://bmcsystbiol.biomedcentral.com/track/pdf/10.1186/s12918-019-0706-y","source":{"id":"https://openalex.org/S92363890","display_name":"BMC Systems Biology","issn_l":"1752-0509","issn":["1752-0509"],"is_oa":true,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Systems Biology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8299999833106995,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"awards":[{"id":"https://openalex.org/G485075357","display_name":null,"funder_award_id":"11501568","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G8094647107","display_name":null,"funder_award_id":"0931642","funder_id":"https://openalex.org/F4320306076","funder_display_name":"National Science Foundation"},{"id":"https://openalex.org/G8150493524","display_name":null,"funder_award_id":"0931642","funder_id":"https://openalex.org/F4320337380","funder_display_name":"Division of Mathematical Sciences"},{"id":"https://openalex.org/G8606623886","display_name":null,"funder_award_id":"DMS 0931642","funder_id":"https://openalex.org/F4320306076","funder_display_name":"National Science Foundation"}],"funders":[{"id":"https://openalex.org/F4320306076","display_name":"National Science Foundation","ror":"https://ror.org/021nxhr62"},{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320322499","display_name":"Renmin University of China","ror":"https://ror.org/041pakw92"},{"id":"https://openalex.org/F4320337380","display_name":"Division of Mathematical Sciences","ror":"https://ror.org/051fftw81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2941344810.pdf","grobid_xml":"https://content.openalex.org/works/W2941344810.grobid-xml"},"referenced_works_count":70,"referenced_works":["https://openalex.org/W608295237","https://openalex.org/W1518184777","https://openalex.org/W1823780969","https://openalex.org/W1834409279","https://openalex.org/W1893566975","https://openalex.org/W1963851958","https://openalex.org/W1964871165","https://openalex.org/W1977735548","https://openalex.org/W1978541343","https://openalex.org/W1986141346","https://openalex.org/W1997388726","https://openalex.org/W1997851555","https://openalex.org/W2000346327","https://openalex.org/W2012852444","https://openalex.org/W2013520562","https://openalex.org/W2018595535","https://openalex.org/W2022562553","https://openalex.org/W2041441588","https://openalex.org/W2050216284","https://openalex.org/W2062783581","https://openalex.org/W2069496194","https://openalex.org/W2069616255","https://openalex.org/W2077360194","https://openalex.org/W2077630473","https://openalex.org/W2078643379","https://openalex.org/W2088571368","https://openalex.org/W2102282878","https://openalex.org/W2103335284","https://openalex.org/W2106949373","https://openalex.org/W2112154408","https://openalex.org/W2129482327","https://openalex.org/W2130883177","https://openalex.org/W2137626178","https://openalex.org/W2140264799","https://openalex.org/W2142579810","https://openalex.org/W2143512985","https://openalex.org/W2143594415","https://openalex.org/W2144308584","https://openalex.org/W2144893998","https://openalex.org/W2146099965","https://openalex.org/W2150544967","https://openalex.org/W2150654884","https://openalex.org/W2152803686","https://openalex.org/W2152948584","https://openalex.org/W2154670252","https://openalex.org/W2156906256","https://openalex.org/W2160121844","https://openalex.org/W2161261098","https://openalex.org/W2165831623","https://openalex.org/W2166918177","https://openalex.org/W2171172959","https://openalex.org/W2171676198","https://openalex.org/W2179115666","https://openalex.org/W2196610251","https://openalex.org/W2339025832","https://openalex.org/W2405958927","https://openalex.org/W2466587221","https://openalex.org/W2473347405","https://openalex.org/W2511951051","https://openalex.org/W2546466212","https://openalex.org/W2556495987","https://openalex.org/W2567777922","https://openalex.org/W2604391908","https://openalex.org/W2607357764","https://openalex.org/W2619891302","https://openalex.org/W2737025620","https://openalex.org/W2765939742","https://openalex.org/W2981647581","https://openalex.org/W4211226325","https://openalex.org/W4213281733"],"related_works":["https://openalex.org/W4403621565","https://openalex.org/W2763939289","https://openalex.org/W1603230122","https://openalex.org/W2041613012","https://openalex.org/W132539193","https://openalex.org/W2058775893","https://openalex.org/W2405725087","https://openalex.org/W2123019622","https://openalex.org/W2019228596","https://openalex.org/W2013913223"],"abstract_inverted_index":{"BACKGROUND:":[0],"One":[1],"of":[2,8,14,42,67,79,97,124,143,162],"the":[3,6,23,32,40,43,48,68,77,95,106,111,125,144,160,174],"questions":[4],"in":[5,18,31,61,105,159],"design":[7,161],"cancer":[9],"clinical":[10,163],"trials":[11,164],"with":[12,39,165],"combination":[13,166],"two":[15,126],"drugs":[16,69,90],"is":[17,26,70,73,116,130],"which":[19,72],"order":[20],"to":[21,56,75,93,134,149],"administer":[22],"drugs.":[24,81],"This":[25],"an":[27,156],"important":[28,157],"question,":[29],"especially":[30],"case":[33,64,107],"where":[34,65,108,168],"one":[35,66],"agent":[36],"may":[37,171],"interfere":[38],"effectiveness":[41],"other":[44,80,150],"agent.":[45],"RESULTS:":[46],"In":[47],"present":[49],"paper":[50,145],"we":[51,86],"develop":[52],"a":[53,62,83,113,121],"mathematical":[54],"model":[55],"address":[57],"this":[58],"scheduling":[59,169],"question":[60],"specific":[63],"anti-VEGF,":[71],"known":[74,92],"affect":[76,173],"perfusion":[78],"As":[82],"second":[84],"drug":[85],"take":[87],"anti-PD-1.":[88],"Both":[89],"are":[91],"increase":[94],"activation":[96],"anticancer":[98],"T":[99],"cells.":[100],"Our":[101],"simulations":[102],"show":[103],"that":[104],"anti-VEGF":[109],"reduces":[110],"perfusion,":[112],"non-overlapping":[114],"schedule":[115],"significantly":[117,172],"more":[118,132],"effective":[119],"than":[120],"simultaneous":[122],"injection":[123],"drugs,":[127],"and":[128,141,152],"it":[129],"somewhat":[131],"beneficial":[133],"inject":[135],"anti-PD-1":[136],"first.":[137],"CONCLUSION:":[138],"The":[139],"method":[140],"results":[142],"can":[146],"be":[147],"extended":[148],"combinations,":[151],"they":[153],"could":[154],"play":[155],"role":[158],"therapy,":[167],"strategies":[170],"outcome.":[175]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3}],"updated_date":"2026-05-06T08:25:59.206177","created_date":"2025-10-10T00:00:00"}